Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Madhav Dhodapkar
multiple myeloma immunotherapy
Bruno Paiva
smoldering myeloma
Carl June
CAR T immunotherapy
Jing Yang
Myeloma
Jonathan Licht
DNA biology, myeloma
Lev Kats
myeloma and epigenetics
Qing Yi
Novel CAR-T
Nizar Bahlis
Myeloma immunotherapy
Simona Colla
Myeloma biology
Shirong Li
myeloma
John Leonard
lymphoma research
Caroline Arber
myeloma CAR-T
F. Lennie Wong
Equity in Access
Eugenio Morelli
Myeloma
William Matsui
Myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Alfred Garfall
myeloma immunotherapy
Mala Shanmugam
myeloma
Gareth Morgan
smoldering myeloma, MGUS
Jianhua Yu
myeloma immunotherapy
David Fruman
novel combinations
Alec Zhang
myeloma, immunotherapy
Ruben Carrasco
Myeloma
Tanya Siddiqi
clinical trial access
Matteo Bellone
Smoldering multiple myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Helen Heslop
Immunotherapy
Amin Sobh
Myeloma biology
Brian Walker
smoldering myeloma, MGUS
Christopher Flowers
clinical trial access
Lawrence Boise
CART and myeloma
Noemí Puig Morón
Myeloma
Jun Qi
Myeloma
Suzanne Lentzsch
Myeloma
Armin Rashidi
gut bacteria and transplant success
Ricky Johnstone
lymphoma and myeloma
Sigurður Kristinsson
Smoldering myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy